KHAN NAJAT (CEO and President) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/18/2026ACC: 0002020969-26-000006
DirectorOfficer· CEO and President
Since Feb 2026
-80.50K
Net shares
Net seller
$254.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
80.50K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−80.50K
Price / share
$3.16
Trade value
$254.37K
% of position
3.7%
8/17/2026
2.18M→2.10M
Total
Net shares
−80.50K
Net value
-$254.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/17/2026 | F · Tax Withholding | −80.50K | $3.16 | $254.37K | 3.7% | 2.18M | 2.10M |
| Total | −80.50K | -$254.37K | ||||||
Derivative Transactions0
No derivative transactions reported